A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen.
| Website | https://www.epitopea.com/ |
| Revenue | $21.9 million |
| Employees | 51 (34 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology |
| Keywords | Therapeutics, Cancer Treatment, Biotechnology, Drug Development, New Drug Discovery, Targeted Therapy, Pharmaceutical, Immunotherapy, Oncology, Biopharma, Therapeutic Antibodies, Cancer Research, Precision Medicine, Antibody Engineering, Biologics, Clinical Trials |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Amgen, Regeneron, Immunovant, Lilly India +33 more (view full list) |
Looking for a particular Epitopea employee's phone or email?
The Epitopea annual revenue was $21.9 million in 2026.
Alan Rigby is the CEO of Epitopea.
34 people are employed at Epitopea.
Epitopea is based in Montreal, Quebec.